1-5 of 5
Roy Hartvig Larsen, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination of 177 lutetium-Satetraxetan-Lilotomab and Rituximab Results in Improved Therapeutic Effect in Preclinical Models of Non-Hodgkin Lymphoma

Free
Ada H.V. Repetto-Llamazares, PhD, Roy Hartvig Larsen, PhD, Adam O'Shea, Jostein Dahle
Journal: Blood
Blood (2016) 128 (22): 4189.
https://doi.org/10.1182/blood.V128.22.4189.4189
Published: 2016
Journal Articles

Efficacy and Safety Results of a Phase 1 Study of 177 lu-DOTA-HH1 (Betalutin ® ) with and without HH1 Pre-Dosing for Patients with Relapsed CD37+ Non-Hodgkin B Cell Lymphoma (NHL)

Free
Arne Kolstad, MD PhD, Ulf Madsbu, MD, Bjørg Bolstad, MSc, Caroline Stokke, PhD, Tore Bach-Gansmo, MD PhD, Ayca Muftuler Løndalen, MD, Jon Erik Holtedahl, MSc, Mona Elisabeth Revheim, MD PhD, Øyvind Bruland, MD PhD, Jostein Dahle, PhD, Nils Bolstad, MD, Roy Hartvig Larsen, PhD, Signe Spetalen, MD, Martin Erlanson, MD PhD, Stine Nygaard Rudå, Harald Holte, Jr., MD PhD
Journal: Blood
Blood (2015) 126 (23): 5118.
https://doi.org/10.1182/blood.V126.23.5118.5118
Published: 2015
Journal Articles

Treatment with 177 lu-HH1 Increases CD20 Expression in Non-Hodgkin Lymphoma Cells in Vitro and In Vivo

Free
Ada H.V. Repetto-Llamazares, PhD, Roy Hartvig Larsen, PhD, Landsverk Kirsti, PhD, Trond Stokke, PhD, Bergthora Eiriksdottir, PhD, Roman Generalov, MSc, Jostein Dahle, PhD
Journal: Blood
Blood (2015) 126 (23): 3245.
https://doi.org/10.1182/blood.V126.23.3245.3245
Published: 2015
Journal Articles

A Phase I Study of 177 lu-DOTA-HH1 (Betalutin) Radioimmunotherapy for Patients with Relapsed CD37+ Non-Hodgkin's B Cell Lymphoma

Free
Arne Kolstad, MD PhD, Ulf Madsbu, MD, Jostein Dahle, PhD, Caroline Stokke, PhD, Tore Bach-Gansmo, MD PhD, Ayca Muftuler Løndalen, MD, Jon Erik Holtedahl, MSc, Mona Elisabeth Revheim, MD PhD, Øyvind Bruland, MD PhD, Bjørg Bolstad, MSc, Nils Bolstad, MD, Anne Tierens, MD PhD, Roy Hartvig Larsen, PhD, Jan Alan Alfheim, MSC, MBA, Jan Delabie, MD PhD, Spetalen Signe, MD, Martin Erlanson, MD PhD, Stine Nygaard Rudå, Harald Holte, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3094.
https://doi.org/10.1182/blood.V124.21.3094.3094
Published: 2014
Journal Articles

Re-Evaluation of CD37 As Target for Radioimmunotherapy of Non-Hodgkin Lymphoma,

Free
Jostein Dahle, PhD, Ada Repetto, Camilla Sivertsen Mollatt, Katrine Brustad Melhus, Øyvind Sverre Bruland, MD, PhD, Arne Kolstad, MD, PhD, Roy Hartvig Larsen, PhD
Journal: Blood
Blood (2011) 118 (21): 3732.
https://doi.org/10.1182/blood.V118.21.3732.3732
Published: 2011